Analyst firms · Barclays · ELAN

Barclays ELAN price target and rating history

Elanco Animal Health Incorporated (ELAN) · Health Care

Barclays rates Elanco Animal Health Incorporated (ELAN) Overweight with a $30 price target, as of its latest action on Dec 9, 2025. It has published 3 rating actions on ELAN since February 2022, including 1 upgrade and 0 downgrades. Across 6 firms with a ELAN price target in the last 12 months, the median target is $28.50. Barclays's $30 is 5% above that.

Current rating
Overweight
Price target
$30
Median target, all firms
$28.50
Actions on ELAN
3

Barclays price target on ELAN

$32$23$142023202420252026
Barclays price target on ELAN, each point a stated target, February 2022 to December 2025.

Every Barclays rating on ELAN

How other firms rate ELAN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
JefferiesHold$24Oct 20, 2026
Goldman SachsBuy$32Oct 16, 2026
CitigroupBuy$30Apr 15, 2026
Piper SandlerOverweightJan 22, 2026
BarclaysOverweight$30Dec 9, 2025
KeyBanc Capital MarketsOverweight$27Nov 21, 2025
Argus ResearchBuy$25Nov 19, 2025

Questions about Barclays and ELAN

What is Barclays's price target for ELAN?
Barclays's latest stated price target for Elanco Animal Health Incorporated (ELAN) is $30, from its action on Dec 9, 2025.
What is Barclays's rating on ELAN?
Barclays rates ELAN Overweight, a bullish rating, as of Dec 9, 2025.
When did Barclays last change its view on ELAN?
On Dec 9, 2025, Barclays starts coverage at Overweight, price target $30.
How does Barclays's ELAN target compare with other analysts?
Across 6 firms with a ELAN price target in the last 12 months, the median target is $28.50. Barclays's $30 is 5% above that.

More ELAN rating histories

All Barclays ratingsELAN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.